MENU
MNKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MannKind (MNKD) Ownership - Who owns MannKind?
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.52B
P/E Ratio
50.20
Total Cash
197.26M
Projected Growth
N/A
Total Debt
47.7M
Revenue
285.5M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
992.55
Revenue/Share
1.01 USD as % of share price
Fundamentals
MNKD
Capitalization
1.52B
P/E Ratio
50.20
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
197M
Total Cash/Share
0.65
Total Debt
47.7M
Total Debt/Equity
992.55
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.01%
Revenue
286M
ROE
N/A
Book Value
-78.82M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.03M
Current Ratio
3.28
Current Revenue Per Employee
188638.83
Dividends Per Share - Security
N/A
EBITDA
77.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.47
Revenue To Assets
6.35
Shares Held By Institutions
1.49B
Shares Outstanding - Current
304M
Total Liabilities
473M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-21.928
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com